先天性心脏病患者22q11.2区域变异的遗传特征与患病率
该研究对354例接受手术的先天性心脏病(CHD)患儿进行22q11.2区域检测,发现40例(11.3%)携带不同水平的缺失/扩增,涉及CDC45、TBX1等基因,其中2例分别携带3Mb典型缺失和1.5Mb缺失。结论提示CHD患儿中22q11.2变异患病率高于预期,即使简单缺陷也存在,建议所有CHD患者进行22q11.2遗传检测。
要点
- CHD手术患儿中22q11.2缺失/扩增检出率为11.3%(40/354)。
- 变异涉及CDC45(15例)、TBX1(8例)、USP18(8例)等基因。
- 2例分别携带3Mb(CLTCL1-LZTR1)和1.5Mb(CLTCL1-MED15)缺失。
核心结论
- CHD患儿中22q11.2变异患病率高于预期,即使简单缺陷也存在。
- 基因型-表型关系分析提示所有CHD患者可能需要22q11.2遗传检测。
- 检测独特缺失或扩增可能为CHD患者个体化管理提供有用见解。
研究设计与样本
- 对接受手术的CHD患者采用多重连接依赖探针扩增和毛细管电泳方法筛查。
- 应用通用探针库技术进行验证。
- 共纳入354例CHD患者。
主要发现
- 354例CHD患者中40例(11.3%)携带不同水平的22q11.2区域缺失/扩增,表型多样。
- 受累基因包括CDC45(15例)、TBX1(8例)、USP18(8例)、RTDR1(7例)、SNAP29(6例)、TOP3B(6例)、ZNF74(4例)及其他频率较低的基因。
- 2例分别携带从CLTCL1到LZTR1的3Mb典型缺失区域(低拷贝重复A-D)或从CLTCL1到MED15的1.5Mb缺失(低拷贝重复A-C)。
- 12例患者发现临床面部表现。
关键数值与推荐
- 22q11.2缺失/扩增在354例CHD患者中检出40例(11.3%)。
- 受累基因例数:CDC45 15例、TBX1 8例、USP18 8例、RTDR1 7例、SNAP29 6例、TOP3B 6例、ZNF74 4例。
- 2例携带3Mb(CLTCL1-LZTR1)或1.5Mb(CLTCL1-MED15)缺失。
- 12例患者有临床面部表现。
临床怎么用
- 对CHD患儿(包括简单缺陷)考虑进行22q11.2区域遗传检测。
- 检测缺失/扩增的具体类型可能有助于个体化管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The 22q11.2 deletion syndrome is considered the most frequent chromosomal microdeletion syndrome in humans and the second leading chromosomal cause of congenital heart disease (CHD). We aimed to identify the prevalence and the detailed genetic characterisation of 22q11.2 region in children with CHD including simple defects and to explore the genotype-phenotype relationship between deletion/amplification type and clinical data. METHODS: Patients with CHD for surgery were screened by multiplex ligation-dependent probe amplification and capillary electrophoresis methods. Universal Probe Library technology was applied for validation. RESULTS: In 354 patients with CHD, 40 (11.3%) carried different levels of deletions/amplifications at the 22q11.2 region with various phenotypes. The affected genes at this region include CDC45 (15 patients), TBX1 (8), USP18 (8), RTDR1 (7), SNAP29 (6), TOP3B (6), ZNF74 (4) and other genes with less frequency. Among those, two patients carried 3 Mb typically deleted region from CLTCL1 to LZTR1 (low copy repeats A-D) or 1.5 Mb deletions from CLTCL1 to MED15 (low copy repeats A-C). Clinical facial manifestations were found in 12 patients. CONCLUSIONS: This study revealed an unexpected high prevalence of chromosome 22q11.2 variations in patients with CHD even in simple defects. The genotype-phenotype relationship analysis suggests that genetic detection of 22q11.2 may become necessary in all patients with CHD and that detection of unique deletions or amplifications may provide useful insight into personalised management in patients with CHD.
引用
- Hou HT, Chen HX, Wang XL, et al. Genetic characterisation of 22q11.2 variations and prevalence in patients with congenital heart disease. Arch Dis Child. 2019. PMID: 31666243. doi:10.1136/archdischild-2018-316634
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。